United Therapeutics Corporation
Martine A Rothblatt (Chairperson & CEO) sells UTHR shares
AI-generated summary
Chairperson & CEO, Director Martine A Rothblatt exercised options for 9,500 shares valued at $1,118,720 and sold 9,500 shares for $5,627,991 through a trust. Following these transactions, the insider indirectly holds 324,443 shares. The trades were executed under a Rule 10b5-1 trading plan adopted on November 7, 2025.
Key facts
- Insider
- Martine A Rothblatt · Chairperson & CEO, Director
Rule 10b5-1 plan · adopted Nov 7, 2025
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | M · exercise or conversion of a derivativeFootnotes F1, F2 | +9,500 | $117.76 | $1,118,720.00 | 333,943 | Indirect (by Trust) |
| Nov 13, 2026 | S · open-market saleFootnotes F1, F3, F2 | −528 | $587.42 | $310,156.28 | 333,415 | Indirect (by Trust) |
| Nov 13, 2026 | S · open-market saleFootnotes F1, F4, F2 | −493 | $588.61 | $290,183.05 | 332,922 | Indirect (by Trust) |
| Nov 13, 2026 | S · open-market saleFootnotes F1, F5, F2 | −603 | $589.80 | $355,646.51 | 332,319 | Indirect (by Trust) |
| Nov 13, 2026 | S · open-market saleFootnotes F1, F6, F2 | −1,657 | $590.65 | $978,701.58 | 330,662 | Indirect (by Trust) |
| Nov 13, 2026 | S · open-market saleFootnotes F1, F7, F2 | −2,181 | $591.56 | $1,290,197.81 | 328,481 | Indirect (by Trust) |
| Nov 13, 2026 | S · open-market saleFootnotes F1, F8, F2 | −518 | $592.61 | $306,973.27 | 327,963 | Indirect (by Trust) |
| Nov 13, 2026 | S · open-market saleFootnotes F1, F9, F2 | −245 | $593.81 | $145,482.91 | 327,718 | Indirect (by Trust) |
| Nov 13, 2026 | S · open-market saleFootnotes F1, F10, F2 | −1,275 | $594.65 | $758,183.85 | 326,443 | Indirect (by Trust) |
| Nov 13, 2026 | S · open-market saleFootnotes F1, F11, F2 | −1,040 | $595.41 | $619,231.08 | 325,403 | Indirect (by Trust) |
| Nov 13, 2026 | S · open-market saleFootnotes F1, F12, F2 | −480 | $596.65 | $286,390.85 | 324,923 | Indirect (by Trust) |
| Nov 13, 2026 | S · open-market saleFootnotes F1, F13, F2 | −440 | $597.48 | $262,891.02 | 324,483 | Indirect (by Trust) |
| Nov 13, 2026 | S · open-market saleFootnotes F1, F2 | −40 | $598.83 | $23,953.20 | 324,443 | Indirect (by Trust) |
| Nov 13, 2026 | M · exercise or conversion of a derivativeStock OptionFootnotes F1, F17, F18 | −9,500 | $0.00 | $0.00 | 24,410 | Indirect (by Trust) |
Footnotes
- F1 This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10 This transaction was executed in multiple trades at prices ranging from $594.15 to $595.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11 This transaction was executed in multiple trades at prices ranging from $595.17 to $596.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12 This transaction was executed in multiple trades at prices ranging from $596.18 to $597.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13 This transaction was executed in multiple trades at prices ranging from $597.25 to $598.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14 Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F15 Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F16 Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F17 These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.
- F18 Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F2 Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F3 This transaction was executed in multiple trades at prices ranging from $587.01 to $588.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4 This transaction was executed in multiple trades at prices ranging from $588.09 to $589.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5 This transaction was executed in multiple trades at prices ranging from $589.12 to $590.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6 This transaction was executed in multiple trades at prices ranging from $590.12 to $591.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7 This transaction was executed in multiple trades at prices ranging from $591.12 to $592.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8 This transaction was executed in multiple trades at prices ranging from $592.13 to $593.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9 This transaction was executed in multiple trades at prices ranging from $593.15 to $594.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
More UTHR filings
- 4
Filed Nov 19, 2026
- 4
Filed Nov 19, 2026
- 144
Filed Nov 19, 2026
- 4
Filed Nov 18, 2026
- 4
Filed Nov 17, 2026
- 4
Filed Nov 13, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.